ScholarIQanswers from OpenAlex & ORCID
Margot Tesselaar
ResearcherPublications, citations & collaboration network
Margot Tesselaar is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Margot Tesselaar have?
ScholarIQindexed works
Margot Tesselaar has 182 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Margot Tesselaar have?
ScholarIQcitation count
Margot Tesselaar has 6,997 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Margot Tesselaar?
ScholarIQh-index
Margot Tesselaar has an h-index of 40 in OpenAlex.
What is the i10-index of Margot Tesselaar?
ScholarIQi10-index
Margot Tesselaar has an i10-index of 86 in OpenAlex.
What is the ORCID of Margot Tesselaar?
ScholarIQorcid
The ORCID for Margot Tesselaar is on the source record.
What is the OpenAlex record for Margot Tesselaar?
ScholarIQopenalex
The OpenAlex for Margot Tesselaar is on the source record.
What are the most-cited papers on Margot Tesselaar?
ScholarIQmost cited works
Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
James C. Yao, Nicola Fazio, Simron Singh, Roberto Buzzoni, Carlo Carnaghi, Edward M. Wolin, Jiří Tomášek, Markus Raderer, Harald Lahner, Maurizio Voi, Lida Pacaud, Nicolas Rouyrre, Carolin Sachs, Juan W. Valle, Gianfranco Delle Fave, Eric Van Cutsem, Margot Tesselaar, Yasuhiro Shimada, Do‐Youn Oh, Jonathan Strosberg, Matthew H. Kulke, Marianne Pavel
Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial
Miriam Koopman, Ninja Antonini, Joep Douma, J. Wals, Aafke H. Honkoop, Frans Erdkamp, Robert S. de Jong, C. J. Rodenburg, Gerard Vreugdenhil, O. J. L. Loosveld, Aart van Bochove, Harm Sinnige, Geert-Jan Creemers, Margot Tesselaar, P. H. Th. J. Slee, M.J.B.P. Werter, Linda Mol, Otilia Dalesio, Cornelis J.A. Punt
Microparticle‐associated tissue factor activity: a link between cancer and thrombosis?
Margot Tesselaar, Fred P.H.T.M. Romijn, I K van der Linden, Frans A. Prins, Rogier M. Bertina, S. Osanto
Phase 3 Randomized Trial on Larynx Preservation Comparing Sequential vs Alternating Chemotherapy and Radiotherapy
Jean Louis Lefèbvre, Frédéric Rolland, Margot Tesselaar, É. Bardet, C. René Leemans, Lionnel Geoffrois, P. Hupperets, Luigi Barzan, D. De Raucourt, Dominique Chevalier, Lisa Licitra, F Lunghi, Roger Stupp, Denis Lacombe, Jan Bogaerts, Jean-Claude Horiot, J. Bernier, Jan B. Vermorken, for the EORTC Head and Neck Cancer Cooperative Group and the EORTC Radiation Oncology Group
Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial
H.H. Hartgrink, Cornelis J.�H. van de Velde, Hein Putter, Ilfet Songun, Margot Tesselaar, Elma Meershoek‐Klein Kranenbarg, J.E. de Vries, J. Wils, Jaap van der Bijl, J. Han van Krieken